FDA Closes Recall of Regeneron's Libtayo Injection Over Sterility Assurance
The FDA has closed the Class II recall of Libtayo (cemiplimab-rwlc) Injection, lot 8494000002, initiated by Regeneron Pharmaceuticals over lack of assurance of sterility.
Recalls & Safety Alerts in Tarrytown, New York
Every recalls & safety alerts report published for Tarrytown, New York, newest first.
FDA Recalls Clear Eyes Maximum Itchy Eye Relief Over Sterility Concerns
Prestige Brands Holdings recalls 39,060 bottles of Clear Eyes Maximum Itchy Eye Relief due to potential contamination.
FDA Reports Class II Recall of Siemens Atellica CH Urine Albumin Diagnostic
Siemens Healthcare Diagnostics, Inc. has initiated an ongoing recall of 7018 units of Atellica CH Urine Albumin.